GlaxoSmithKline Intellectual Property Development Limited
发明人:
申请号：
EP14705891.1
公开号：
EP2956452B1
申请日:
2014.02.14
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Disclosed is a compound which is or a tautomer thereof or a salt thereof, pharmaceutical compositions comprising said compound or a tautomer thereof or a pharmaceutically acceptable salt thereof, and the use in the treatment of diseases/disorders which are likely to be regulated at least in part by programmed necrosis, apoptosis or the production of inflammatory cytokines.
